Intuitive Surgical, Inc.
ISRG · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 6.22B | 4.20B | 1.58B | 1.32B | 3.72 |
| 2023 FY | 7.12B | 4.73B | 1.77B | 1.80B | 5.12 |
| 2024 FY | 8.35B | 5.63B | 2.35B | 2.32B | 6.54 |
| 2025 FY | 10.06B | 6.64B | 2.95B | 2.86B | 8.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 12.97B | 1.86B | 1.58B | — | 11.04B |
| 2023 FY | 15.44B | 2.04B | 2.75B | — | 13.31B |
| 2024 FY | 18.84B | 2.31B | 2.03B | 146.00M | 16.43B |
| 2025 FY | 20.63B | 2.69B | 3.37B | 302.80M | 17.82B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.49B | -532.40M | 958.40M | — | 294.70M |
| 2023 FY | 1.81B | -1.06B | 749.60M | — | 1.17B |
| 2024 FY | 2.42B | -1.11B | 1.30B | — | -707.70M |
| 2025 FY | 3.03B | -539.80M | 2.49B | — | 1.35B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 94.38B | 92.80B | — | — | — |
| 2023 FY | 118.48B | 115.73B | — | — | — |
| 2024 FY | 185.40B | 183.52B | — | — | — |
| 2025 FY | 202.13B | 199.07B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q3 | 2.51B | 1.66B | 759.70M | 704.40M | 1.98 |
| 2025 Q4 | 2.87B | 1.90B | 864.30M | 794.80M | 2.24 |
| 2026 Q1 | 2.77B | 1.83B | 855.30M | 821.50M | 2.31 |
| 2026 Q2 | 2.89B | 1.96B | 971.90M | 818.10M | 2.32 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q3 | 19.35B | 2.31B | 2.81B | — | 16.93B |
| 2025 Q4 | 20.63B | 2.69B | 3.37B | 302.80M | 17.82B |
| 2026 Q1 | 20.11B | 2.51B | 2.04B | — | 17.47B |
| 2026 Q2 | 20.88B | 2.58B | 8.63B | — | 18.30B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 715.40M | -155.30M | 560.10M | — | 829.30M |
| 2025 Q3 | 841.00M | -105.40M | 735.60M | — | -597.00M |
| 2025 Q4 | 892.50M | -162.50M | 730.00M | — | 561.40M |
| 2026 Q1 | 911.90M | -103.30M | 808.60M | — | -1.36B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q3 | 159.48B | 156.68B | — | — | — |
| 2025 Q4 | 201.00B | 197.94B | — | — | — |
| 2026 Q1 | 163.61B | 161.57B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |